Assignee
CARSGEN THERAPEUTICS LTD
CN·3 granted patents·1 pending application·13 citations·filing 2014–2015
Top patents by PatentIndex Score
4 records- 0187US10377822B2Immunologic effector cell of targeted CLD18A2, and preparation method and use thereofCARSGEN THERAPEUTICS LTD·Filed 2015·Granted Aug 13, 2019·5 cites·13 claims
- 0282US10604740B2Nucleic acids encoding chimeric antigen receptor proteins which bind epidermal growth factor receptor and T lymphocyte expressing the proteinCARSGEN THERAPEUTICS LTD·Filed 2014·Granted Mar 31, 2020·5 cites·18 claims
- 0379US10731127B2Chimeric antigen receptors targeting GPC3 and uses thereofCARSGEN THERAPEUTICS LTD·Filed 2014·Granted Aug 4, 2020·3 cites·19 claims
- 0436US2018105595A1Time and space adjustable system for inhibiting pathological target cellsCARSGEN THERAPEUTICS LTD·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →